Insider Transactions in Q2 2022 at Agilon Health, Inc. (AGL)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
106,357
-27.66%
|
$2,339,854
$22.5 P/Share
|
|
Jun 24
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
106,357
+21.66%
|
$106,357
$1.0 P/Share
|
|
Jun 23
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$107,920
$20.08 P/Share
|
|
Jun 23
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
Jun 22
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$102,524
$19.88 P/Share
|
|
Jun 22
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
Jun 10
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$102,524
$19.33 P/Share
|
|
Jun 10
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
Jun 09
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$107,920
$20.9 P/Share
|
|
Jun 09
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
May 31
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$102,524
$19.77 P/Share
|
|
May 31
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
May 27
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$102,524
$19.58 P/Share
|
|
May 27
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
May 25
2022
|
Michael L Smith Director |
SELL
Open market or private sale
|
Indirect |
145,874
-97.25%
|
$2,771,606
$19.53 P/Share
|
|
May 11
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$80,940
$15.95 P/Share
|
|
May 11
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
May 10
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-17.03%
|
$86,336
$16.84 P/Share
|
|
May 10
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
Apr 28
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$97,128
$18.3 P/Share
|
|
Apr 28
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
Apr 27
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$97,128
$18.68 P/Share
|
|
Apr 27
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
Apr 22
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
26,789
-8.78%
|
$535,780
$20.0 P/Share
|
|
Apr 22
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,789
+8.07%
|
$26,789
$1.0 P/Share
|
|
Apr 21
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
79,568
-11.45%
|
$1,591,360
$20.89 P/Share
|
|
Apr 21
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
79,568
+18.19%
|
$79,568
$1.0 P/Share
|
|
Apr 20
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
106,357
-27.66%
|
$2,339,854
$22.34 P/Share
|
|
Apr 20
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
106,357
+21.66%
|
$106,357
$1.0 P/Share
|
|
Apr 19
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
106,357
-27.66%
|
$2,339,854
$22.74 P/Share
|
|
Apr 19
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
106,357
+21.66%
|
$106,357
$1.0 P/Share
|
|
Apr 19
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
6,296
-36.71%
|
$138,512
$22.14 P/Share
|
|
Apr 19
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,296
+26.85%
|
$25,184
$4.49 P/Share
|
|
Apr 18
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
6,477
-37.37%
|
$142,494
$22.64 P/Share
|
|
Apr 18
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,477
+27.21%
|
$25,908
$4.49 P/Share
|
|
Apr 14
2022
|
Timothy Bensley Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,546
+32.22%
|
-
|
|
Apr 14
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,255
+5.52%
|
-
|
|
Apr 14
2022
|
Michelle A Gourdine Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,936
+26.85%
|
-
|
|
Apr 14
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,419
+33.3%
|
-
|
|
Apr 14
2022
|
Sharad Mansukani Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,936
+0.56%
|
-
|
|
Apr 14
2022
|
Karen Mc Loughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,936
+39.95%
|
-
|
|
Apr 14
2022
|
Clay Richards Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,936
+16.31%
|
-
|
|
Apr 14
2022
|
Steven Sell CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
48,765
+50.0%
|
-
|
|
Apr 14
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,546
+14.89%
|
-
|
|
Apr 14
2022
|
Michael L Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,936
+4.18%
|
-
|
|
Apr 14
2022
|
Glenn Sobotka Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,439
+29.97%
|
-
|
|
Apr 14
2022
|
Girish Venkatachaliah Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,837
+39.98%
|
-
|
|
Apr 14
2022
|
Ronald A Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,936
+0.28%
|
-
|
|
Apr 14
2022
|
John William Wulf Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,936
+5.32%
|
-
|
|
Apr 07
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
2,706
-4.06%
|
$67,650
$25.01 P/Share
|